Marie Villedieu

Effect of 2-deoxy-D-glucose on various malignant cell lines in vitro.

Xiao Dong Zhang, E. Deslandes, Marie Villedieu et al. · PubMed · 2006 · 126 citations

Bcl‐<scp>X_L</scp> and MCL‐1 constitute pertinent targets in ovarian carcinoma and their concomitant inhibition is sufficient to induce apoptosis

Émilie Brotin, Matthieu Meryet‐Figuière, Karin Simonin et al. · International Journal of Cancer · 2009 · 110 citations

Chemoprevention Strategy, Apoptosis, Pathology +18

MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer

Paul Vilquin, Caterina F. Donini, Marie Villedieu et al. · Breast Cancer Research · 2015 · 79 citations · Full text

Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment

Marie Villedieu, E. Deslandes, Marilyne Duval et al. · Gynecologic Oncology · 2006 · 53 citations

Progressive Alteration, Oncology, Medicine +8

PI3K/mTOR dual inhibitor NVP-BEZ235 decreases Mcl-1 expression and sensitizes ovarian carcinoma cells to Bcl-xL-targeting strategies, provided that Bim expression is induced

Abdelghani Jebahi, Marie Villedieu, Cécile Pétigny-Lechartier et al. · Cancer Letters · 2014 · 53 citations · Full text

Medicine, Pi3k/mtor Dual Inhibitor, Immunology +12